抗薬に対する薬物相互作用の不一致:電子データベースの比較分析とAIツールによる解釈の洞察
Thitipon Yaowaluk1, Supawit Tangpanithandee2, Pinnakarn Techapichetvanich2
1Drug Information Service and Siriraj Poison Control Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Drug design, development and therapy
|September 2, 2025
まとめ
抗薬と一般的な薬の間の薬物相互作用 (DDI) は,データベースに重大な矛盾を示しています. 人工知能 (AI) は一般的により厳しい評価を好み,安全な患者ケアのための調和した基準と臨床医の意識の必要性を強調しています.
科学分野:
- 薬理学について
- 臨床薬局
- 医療情報学
背景:
- 薬物相互作用 (DDI) は,特に抗剤を含む複数の薬剤が投与された場合,重大な臨床的懸念事項です.
- 抗薬は不可欠ですが,他の薬との有害な相互作用の可能性はあまり研究されていません.
研究 の 目的:
- 一般的に処方される薬と抗薬の間の潜在的なDDIを評価する.
- DDIの識別のための2つの電子データベースと人工知能 (AI) プラットフォームの一致性を評価する.
主な方法:
- よく処方される50の薬と主要な解毒剤を記述的に分析した.
- MicromedexとWebMDのデータベースとChatGPTとGoogle Gemini AIを使用して,潜在的な相互作用が評価されました.
- DDIの重症度,ドキュメントの質,データベース/AIの合意 (kappa統計) が分析されました.
主要な成果:
- 154の潜在的なDDIペアが特定され,データベース間の一致は弱かった (kappa = -0.126).
- メチレンブルーと精神薬が主な原因で,主にセロトニン症候群とQT延長を含む19の重度のDDIが観察されました.
- AIモデルは,不一致の場合にはより厳しいDDI評価と整合する傾向があり,保守的なアプローチを提供しています.
結論:
- データベースとAIの間でDDIの識別に重大な矛盾があるため,評価基準の調和が必要である.
- 臨床医は,安全で効果的な患者のケアを確保するために,データベース間の変動性を認識する必要があります.
- 薬物相互作用の管理には,包括的なDDIスクリーニングと共同意思決定が不可欠です.
関連する概念動画
Agonism and Antagonism: Quantification
557
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
557
Combined Effects of Drugs: Antagonism
9.2K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.2K
Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K
Drug-Receptor Interaction: Antagonist
3.4K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
3.4K
Pharmacovigilance
983
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
983
Drug-Receptor Interactions
5.9K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.9K


